期刊文献+

Caco-2细胞模型的建立及其在真菌毒素吸收率研究中的应用 被引量:5

Development and application of Caco-2 cell lines transfering model for assessing the bioavailability of mycotoxins
原文传递
导出
摘要 目的构建Caco-2单层细胞转运5种毒素的吸收率模型并验证。方法以Caco-2细胞系为工具,以脱氧雪腐镰刀菌烯醇(DON)、黄曲霉毒素B1(AFB1)、AFB2、黄曲霉毒素G1(AFG1)和AFG2为研究对象,通过对转运介质溶液中毒素的初始浓度、温度、pH值、抑制剂存在与否等实验条件的优化,构建Caco-2细胞转运DON和4种黄曲霉毒素的生理模型并进行验证。结果DON、AFB1、AFB2、AFG1及AFG2透过Caco-2单层细胞的量和表观渗透系数(Papp)随着体系溶液中pH的升高有下降趋势。AFB,在pH7.4—7.5溶液中的Papp值最高,AFB2、AFG1、AFG2及DON在pH7.0~7.1溶液中的Papp值最高。随着体系温度的升高,DON、AFB1、AFB2、AFG3及AFG2的透膜能力均有所增加。无论体系中AFB1、AFG1及AFG2浓度低或高,均在60min时透过率达到平台期并维持稳定;而AFB,及DON从高浓度到低浓度均在120min时透过率达到平台期并维持稳定。结论所建5种毒素Caco-2单层细胞模型灵敏、稳定、可靠、有效。 Objective The Caco-2 cell model for assessing the bioavailabilities of mycotoxins was developed and validated. Methods The Caco-2 monolayer cell transferring model was developed and validated by optimizing the initial concentrations of toxins in the apical side, the temperature and pH values of the experiment system, and the presence of mycotoxin adsorbent. Results The apparent permeability coefficient(Papp) of AFB1 reached the highest when pH value was in the range between 7.4 and 7.5, while the Papps for DON, AFB2, AFG1 and AFG2were at the highest in the pH value between 7.0 and 7.1, respectively. The permeabilities of these five mycotoxins were increasing along with the temperature ascending. The transmicivities of AFB1, AFG, and AFG2 reached the highest at the incubation time of 60 minutes but 120 minutes for DON and AFB2. Conclusion The developed Caco-2 transferring model of the five mycotoxins was susceptible, stable, effective and reproducible.
出处 《卫生研究》 CAS CSCD 北大核心 2014年第6期923-928,共6页 Journal of Hygiene Research
基金 国家自然科学基金(No.30872124)
关键词 CACO-2细胞模型 脱氧雪腐镰刀菌烯醇 黄曲霉毒素 吸收率 风险 评估 Caco-2 cell model, deoxynivalenol, aflatoxis, bioavailability,risk assessment
  • 相关文献

参考文献9

  • 1UDATA C, PATEL J, PAL D, et al. Enhanced transport of a novel anti-HIV agent cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers[ J ]. Int J Pharm,2003, 250 ( 1 ) :157-685.
  • 2OOMEN A G, BRANDON E F A, SWARTJES F A. How can information on oral bioavailability improve human health risk assessment for lead-contaminated soils? Implementation and scientific basis [ R ]. RIVM Report, No. 711701042/2006.
  • 3ARTURSSON P , KARLSSON J. Correlation between oral drug absorption in human and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells[ J]. Biochem Biophys Res Commun, 1991, 175 (3) : 880-885.
  • 4GAN L S, THANKKER D R. Applications of the Caco-2 model in the design and development of biochemical and physical barriers posed by the intestinal epithelium [ J ]. Adv Drug Delivery Rev, 1997, 23 (13) : 77-98.
  • 5YEE S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo ( small intestinal ) absorption in man2fact or myth [ J ]. Pharm Res, 1997,14 (6) : 763-766.
  • 6UDATA C, PATEL J, PAL D, et al. Enhanced transport of a novel anti-HIV agent 2 cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers [ J]. Int J Pharm,2003, 250 (1) : 157-685.
  • 7YAMASHITA S, FURUBAYASHI T, KATAOKA M, et al. Optimized conditions for prediction of intestinal drug permeability using Caco-2 ceils [ J]. Eur J Pharm Sci ,2000, 10 (3) :195-204.
  • 8于钏钏,邵兵,李凤琴,于红霞.粮食中隐蔽型脱氧雪腐镰刀菌烯醇等多组分真菌毒索协同检测技术[J].中华预防医学杂志,2010,44(8):736-740. 被引量:17
  • 9DEAN J R, SCOTT W C. Reccent developments in assessing the bioavailability of persistent organic pollutants in the environment [ J ]. TrAC-Trends Anal Chem, 2004, 23(9) : 609-618.

二级参考文献5

  • 1Poppenberger B,Berthiller F,Lucyshyn D,et al.Detoxification of the Fusarium mycotoxin deoxynivalenol by a UDP-glucosyltransferase from Arabidopsis thaliana.J Biol Chem,2003,278:47905-47914.
  • 2Ruprich J,Ostr(y) V.Immunochemical methods in health risk assessment:cross reactivity of antibodies against mycotoxin deoxynivalenol with deoxynivalenol-3-glucoside.Cent Eur J Public Health,2008,16:34-37.
  • 3The Council of the European Union.On measures to monitor certain substances and residues thereof in live animals and animal products and repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC.1996-04-29.
  • 4Berthiller F,Dall' Asta C,Schuhmacher R,et al.Masked mycotoxins:determination of a deoxynivalenol glucoside in artificially and naturally contaminated wheat by liquid chromatography-tandem mass spectrometry.J Agric Food Chem,2005,53:3421-3425.
  • 5Sulyok M,Berthiller F,Krska R,et al.Development and validation of a liquid chromatography/tandem mass spectrometric method for the determination of 39 mycotoxins in wheat and maize.Rapid Commun Mass Spectrom,2006,20:2649-2659.

共引文献16

同被引文献67

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部